Table 2 Details of patients affected by breast cancer under bone modifying agents for CTIBL
N. 15 BC patients with CTIBL (%) | |
|---|---|
Median age | 68 |
Mean age ± SD | 67.5 ± 11 |
Comorbidities | Yes 8 (53.3) |
No 7 (46.7) | |
Diabetes | 2 (13.3) |
Hypertension | 7 (46.7) |
HCV-related hepatopathy | 0 |
Arthrosis | 1 (6.7) |
Cardiovascular diseases | 0 |
Corticosteroid therapy | 5(33.3) |
Site of MRONJ | |
Mandible | 11 (73.3) |
Maxilla | 4 (26.7) |
Mandible and Maxilla | 0 |
Oral trigger for MRONJ | Yes 10 (66.7) |
No 5 (33.3) | |
Tooth extraction | 6 (40) |
Periodontal disease | 3 (20) |
Peri-implantitis | 1 (6.66) |
Prosthetic trauma | 0 |
MRONJ stage according to AAOMS | |
1 | 5 (33.3) |
2 | 6 (40) |
3 | 4 (26.7) |
MRONJ stage according to SICMF–SIPMO | |
1 | 5 (33.3) |
2 | 6 (40) |
3 | 4 (26.7) |